The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival

Melanoma Research

Volumn 10, Issue 2, 2000, Pages 113-118

  Aubin, F ^a   Chtourou, M ^a   Teyssier, J R ^b   Laubriet, A ^b   Mougin, C H ^a   Blanc, D ^a   Humbert, Ph ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

Author keywords

Melanoma; RT PCR; Tyrosinase mRNA

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

AGAR GEL ELECTROPHORESIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; GENE EXPRESSION; HUMAN; MELANOMA; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034021484     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200004000-00003     Document Type: Article

References (24)

1. 1. Balch CM, Soong SJ, Shaw HM, Urist MM, McCarthy WH. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. Philadelphia: JB Lippincott, 1992: 165-187.
2. 2. Richard MA, Grob JJ, Avril MF, Delaunay M, Thirion X, Wolkenstein P, Souteyrand P, Dreno B, Bonerandi JJ, Dalac S, Machet L, Guillaume JC, Chevrant-Breton J, Vilmer C, Aubin F, Guillot B, Beylot-Barry M, Lok C, Raison-Peyron N, Chemaly P. Melanoma and tumour thickness: challenges of early diagnosis. Arch Dermatol 1999; 135: 269-274.
3. 3. Kirkwood JM. Systemic adjuvant treatment of high-risk melanoma: the role of interferon alpha-2b and other immunotherapies. Eur J Cancer 1998; 34: S12-S17.
4. 4. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338: 1227-1229.
5. 5. Brossart P, Keilholz U, Willhauck M, Scheibenbogen C, Möhler T, Hunstein W. Hematogenous spread of malignant melanoma cells in different stages of diseases. J Invest Dermatol 1993; 101: 887-889.
6. 6. Vormwald-Dogan V, Nickel P, Willemse M, Thome M, Tilgen W. Prevalence of melanoma cells in peripheral blood of patients with malignant melanoma stage I-IV: detection by polymerase chain reaction. J Invest Dermatol 1994; 103: 402-405.
7. 7. Battayani Z, Grob JJ, Xerri L, Noe C, Zarour H, Houvaeneghel G, Delpero JR, Birmbaum D, Hassoun J, Bonerandi JJ. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma. Arch Dermatol 1995; 131: 443-447.
8. 8. Kunter U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J. Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma. J Natl Cancer Inst 1996; 88: 590-594.
9. 9. Mellado B, Collomer D, Castel T, Munoz M, Carballo E, Galan M. Detection of circulating neoplastic cells by reverse transcriptase-polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 1996; 14: 2091-2097.
10. 10. Tessier MH, Denis MG, Lustenberger P, Dreno B. Detection de cellules mélaniques circulantes par transcription inverse et réaction de polymérisation en chaîne dans les mélanomes. Ann Dermatol Venereol 1997; 124: 607-611.
11. 11. Gläser R, Rass K, Seiter S, Hauschild A, Christophers E, Tilgen W. Detection of circulating melanoma cells by specific amplification of tyrosinase complementary DNA is not a reliable tumor marker in melanoma patients: a clinical two-center study. J Clin Oncol 1997; 15: 2818-2825.
12. 12. Reinhold U, Lüdtke-Handjery HC, Schnautz S, Kreysel HW, Abken H. The analysis of tyrosinase-specific mRNA in blood samples of melanoma patients by RT-PCR is not a useful test for metastatic tumor progression. J Invest Dermatol 1997; 108: 166-169.
13. 13. Farthmann B, Eberle J, Krasagakis K, Gstöttner M, Wang N, Bisson S, Orfanos CE. RT-PCR for tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients. J Invest Dermatol 1998; 110: 263-267.
14. 14. Sardi I, Moretti S, Ponchietti R, Arrigucci S, Guazzelli R, Montali E. The role of the detection of hematogenous micrometastasis in prostate adenocarcinoma and malignant melanoma by RT-PCR. Int J Mol Med 1999; 3: 417-419.
15. 15. Carrillo E, Marchal JA, Prados J, Melguizo C, Velez C, Arena N, Alvarez L, Serrano S, Aranega A. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction. Cell Mol Biol 1998; 44: 1247-1252.
16. 16. Pittman K, Burchill S, Smith B, Southgate J, Joffe J, Gore M, Selby P. Reverse transcriptase-polymerase chain reaction for expression of tyrosinase to identify malignant melanoma cells in peripheral blood. Ann Oncol 1996; 7: 297-301.
17. 17. Curry BJ, Smith MJ, Hersey P. Detection and quantitation of melanoma cells in the circulation of patients. Melanoma Res 1996; 6: 45-54.
18. 18. Jung FA, Buzaid AC, Ross MI, Woods KV, Lee JJ, Albitar M, Grimm EA. Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients. J Clin Oncol 1997; 15: 2826-2831.
19. 19. Ghossein RA, Coit D, Brennan M, Zhang ZF, Wang Y, Bhattacharya S, Houghton A, Rosai J. Prognostic significance of peripheral blood and bone marrow tyrosinase RNA in malignant melanoma. Clin Cancer Res 1998, 4: 419-428.
20. 20. McNeer G, Gupta TD. Prognosis in malignant melanoma. Surgery 1964; 56: 512-518.
21. 21. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
22. 22. Keilholz II, Willhauck M, Rimoldi D, Brasseur F, Dummer W, Rass K, de Vries T, Blaheta J, Voit C, Lethé B, Burchill S. Reliability of reverse transcription-polymerase chain reaction (RT-PCR)-based assays for the detection of circulating tumor cells: a quality-assurance initiative of the EORTC Melanoma Cooperative Group. Eur J Cancer 1998; 34: 750-753.
23. 125I-5-iodo-2-deoxyuridine. J Natl Cancer Inst 1970; 45: 773-776.
24. 24. De Vries TJ, Fourkour A, Punt CJ, van de Locht LT, Wobbes T, van den Bosch S, de Rooij MJ, Mensink EJ, Ruiter DJ, van Muijen GN. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR. Br J Cancer 1999; 80: 883-891.